New York Life Investment Management’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

New York Life Investment Management’s Portfolio PTVE Stock Details PTVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-461,736	Closed	-$8.32M	–	856
2025 Q1	$8.32M	Buy	+461,736	New	+$8.21M	0.08%	215
2024 Q1	–	Sell	-43,336	Closed	-$594K	–	1557
2023 Q4	$594K	Sell	43,336 -1,169	-3%	-$12.3K	0.01%	775
2023 Q3	$362K	Sell	44,505 -7,012	-14%	-$57.3K	﹤0.01%	980
2023 Q2	$390K	Sell	51,517 -8,511	-14%	-$65K	﹤0.01%	1039
2023 Q1	$480K	Buy	+60,028	New	+$617K	0.01%	891

New York Life Investment Management's PTVE Position: Q2 2025 in Review

New York Life Investment Management sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 461,736 shares — an estimated $8.32M sold.

New York Life Investment Management first reported a position in PTVE in Q1 2023 and held it in 5 quarters. The position peaked at $8.32M in Q1 2025. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

New York Life Investment Management reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
New York Life Investment Management sold 461,736 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $8.32M.
New York Life Investment Management first reported a position in Pactiv Evergreen Inc. Common stock in Q1 2023 and held it in 5 quarters.
New York Life Investment Management's Pactiv Evergreen Inc. Common stock position peaked at $8.32M in Q1 2025.
0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.

Based on New York Life Investment Management's 13F filing for Q2 2025, filed 1 Aug 2025.